• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

五个假基因的预后特征可预测低级别胶质瘤。

A prognostic signature of five pseudogenes for predicting lower-grade gliomas.

机构信息

Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.

Department of Neurosurgery, The Second People's Hospital of Hunan Province, The Hospital of Hunan University of Chinese Medicine, Changsha, China.

出版信息

Biomed Pharmacother. 2019 Sep;117:109116. doi: 10.1016/j.biopha.2019.109116. Epub 2019 Jun 24.

DOI:10.1016/j.biopha.2019.109116
PMID:31247469
Abstract

BACKGROUND

A pseudogene is a gene copy that has lost its original coding ability. Pseudogenes participate in numerous biological processes including oncogenesis.

OBJECTIVES

We screened for prognostic pseudogenes for lower-grade glioma (LGG) and explored the potential molecular mechanisms.

METHODS

LGG data downloaded from The Cancer Genome Atlas (TCGA) and the Chinese Glioma Genome Atlas (CGGA) databases were used as training and validation dataset, respectively. Univariate Cox proportional hazard regression was performed to identify pseudogenes with significant prognostic value. Robust likelihood-based survival model and LASSO regression were performed to screen for the most survival-relevant pseudogenes. A risk score model was constructed based on the prognostic pseudogenes to predict the prognosis of LGG patients.

RESULTS

Five pseudogenes (PKMP3, AC027612.4, HILS1, RP5-1132H15.3 and HSPB1P1) were identified as prognostic gene-signatures. Using the risk score model established based on the five pseudogenes, LGG patients were stratified into distinct prognosis groups in both TCGA and CGGA datasets (P < 0.0001). Univariate and multivariate Cox regression analyses confirmed that the risk score generated from the model was an independent prognostic factor in LGG patients (p < 0.05). Furthermore, functional analysis revealed the potential biological mechanisms mediated by the five prognostic pseudogenes.

CONCLUSIONS

Five novel pseudogenes capable of predicting survival in LGG patients were identified. Our findings provide novel insights into the biological role of pseudogenes in LGG.

摘要

背景

假基因是失去原始编码能力的基因副本。假基因参与包括致癌作用在内的许多生物过程。

目的

我们筛选了低级神经胶质瘤(LGG)的预后假基因,并探讨了潜在的分子机制。

方法

使用从癌症基因组图谱(TCGA)和中国神经胶质瘤基因组图谱(CGGA)数据库下载的 LGG 数据作为训练和验证数据集。进行单变量 Cox 比例风险回归以鉴定具有显著预后价值的假基因。进行稳健似然生存模型和 LASSO 回归以筛选与生存最相关的假基因。基于预后假基因构建风险评分模型,以预测 LGG 患者的预后。

结果

鉴定出五个假基因(PKMP3、AC027612.4、HILS1、RP5-1132H15.3 和 HSPB1P1)作为预后基因特征。使用基于这五个假基因建立的风险评分模型,LGG 患者在 TCGA 和 CGGA 数据集均被分为明显不同的预后组(P<0.0001)。单因素和多因素 Cox 回归分析证实,该模型生成的风险评分是 LGG 患者的独立预后因素(p<0.05)。此外,功能分析揭示了五个预后假基因介导的潜在生物学机制。

结论

鉴定出五个可预测 LGG 患者生存的新型假基因。我们的研究结果为假基因在 LGG 中的生物学作用提供了新的见解。

相似文献

1
A prognostic signature of five pseudogenes for predicting lower-grade gliomas.五个假基因的预后特征可预测低级别胶质瘤。
Biomed Pharmacother. 2019 Sep;117:109116. doi: 10.1016/j.biopha.2019.109116. Epub 2019 Jun 24.
2
A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma.弥漫性低级别胶质瘤患者个体化预后评估和放疗指导的五个 miRNA 特征。
J Cell Mol Med. 2020 Jul;24(13):7504-7514. doi: 10.1111/jcmm.15377. Epub 2020 May 15.
3
An autophagic gene-based signature to predict the survival of patients with low-grade gliomas.基于自噬基因的特征预测低级别胶质瘤患者的生存。
Cancer Med. 2021 Mar;10(5):1848-1859. doi: 10.1002/cam4.3748. Epub 2021 Feb 16.
4
SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.SHOX2是预测世界卫生组织II-III级弥漫性胶质瘤患者生存的有效独立生物标志物。
EBioMedicine. 2016 Nov;13:80-89. doi: 10.1016/j.ebiom.2016.10.040. Epub 2016 Oct 28.
5
An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.预测低级别胶质瘤预后的免疫相关标志物。
Front Immunol. 2020 Dec 8;11:603341. doi: 10.3389/fimmu.2020.603341. eCollection 2020.
6
Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.鉴定和验证一种新型的八个突变衍生的长非编码 RNA 特征作为低级别胶质瘤基因组不稳定性的预后生物标志物。
Aging (Albany NY). 2021 Jun 3;13(11):15164-15192. doi: 10.18632/aging.203079.
7
A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.一个四蛋白表达预后标志物预测低级别胶质瘤的临床结局。
Gene. 2018 Dec 30;679:57-64. doi: 10.1016/j.gene.2018.08.001. Epub 2018 Aug 2.
8
TGF-β Score based on Analysis can Robustly Predict Prognosis and Immunological Characteristics in Lower-grade Glioma: The Evidence from Multicenter Studies.基于分析的转化生长因子-β评分能够可靠地预测低级别胶质瘤的预后和免疫特征:来自多中心研究的证据
Recent Pat Anticancer Drug Discov. 2024;19(5):610-621. doi: 10.2174/1574892819666230915143632.
9
Discovery of 5-Signature Predicting Survival of Patients with Lower-Grade Glioma.发现预测低级别胶质瘤患者生存的 5 种特征。
World Neurosurg. 2019 Jun;126:e765-e772. doi: 10.1016/j.wneu.2019.02.147. Epub 2019 Mar 7.
10
Development of a nomogram for prognostic prediction of lower-grade glioma based on alternative splicing signatures.基于剪接变异特征的低级别胶质瘤预后预测列线图的构建。
Cancer Med. 2020 Dec;9(24):9266-9281. doi: 10.1002/cam4.3530. Epub 2020 Oct 13.

引用本文的文献

1
Explainable Machine Learning Models for Glioma Subtype Classification and Survival Prediction.用于脑胶质瘤亚型分类和生存预测的可解释机器学习模型
Cancers (Basel). 2025 Aug 9;17(16):2614. doi: 10.3390/cancers17162614.
2
Anoikis-related genes predicts prognosis and therapeutic response in renal cell carcinoma.失巢凋亡相关基因可预测肾细胞癌的预后和治疗反应。
Ann Med. 2025 Dec;57(1):2548042. doi: 10.1080/07853890.2025.2548042. Epub 2025 Aug 19.
3
Novel signature of ferroptosis-related long non-coding RNA to predict lower-grade glioma overall survival.
用于预测低级别胶质瘤总生存的铁死亡相关长链非编码RNA的新型标志物
Discov Oncol. 2024 Nov 28;15(1):723. doi: 10.1007/s12672-024-01587-9.
4
Comprehensive analysis of the clinical and biological significances of cholesterol metabolism in lower-grade gliomas.全面分析胆固醇代谢在低级别胶质瘤中的临床和生物学意义。
BMC Cancer. 2023 Jul 24;23(1):692. doi: 10.1186/s12885-023-10897-0.
5
N6-methyladenosine-associated prognostic pseudogenes contribute to predicting immunotherapy benefits and therapeutic agents in head and neck squamous cell carcinoma.N6-甲基腺苷相关预后假基因有助于预测头颈部鳞状细胞癌的免疫治疗获益和治疗药物。
Theranostics. 2022 Oct 17;12(17):7267-7288. doi: 10.7150/thno.76689. eCollection 2022.
6
Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.鉴定新型铜死亡相关基因特征并对低级别脑胶质瘤患者进行综合分析。
Front Immunol. 2022 Aug 15;13:933973. doi: 10.3389/fimmu.2022.933973. eCollection 2022.
7
An Ensemble Deep Learning Model with a Gene Attention Mechanism for Estimating the Prognosis of Low-Grade Glioma.一种具有基因注意力机制的集成深度学习模型用于评估低级别胶质瘤的预后
Biology (Basel). 2022 Apr 12;11(4):586. doi: 10.3390/biology11040586.
8
Natural killer cell-related gene signature predicts malignancy of glioma and the survival of patients.自然杀伤细胞相关基因特征可预测脑胶质瘤的恶性程度和患者的生存情况。
BMC Cancer. 2022 Mar 2;22(1):230. doi: 10.1186/s12885-022-09230-y.
9
A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas.由六个免疫基因组成的风险评分特征可预测低级别胶质瘤患者的总生存期。
Comput Math Methods Med. 2022 Feb 11;2022:2558548. doi: 10.1155/2022/2558548. eCollection 2022.
10
The World of Pseudogenes: New Diagnostic and Therapeutic Targets in Cancers or Still Mystery Molecules?假基因的世界:癌症中新的诊断和治疗靶点还是仍然神秘的分子?
Life (Basel). 2021 Dec 7;11(12):1354. doi: 10.3390/life11121354.